Skip to main content

Post-IPO Equity Biotechnology Companies

Explore 483 biotechnology startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
483
Total Funding
$3.7B
Avg Funding
$146.1M
Cities
23

Export 483 Post-IPO Equity Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Indianapolis, United States
$125.0M
raised

Point Biopharma focused on the development and commercialization of radioligand therapies for the treatment of cancer.

Sep 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$20.0M
raised

Codiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics.

Sep 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Lexington, United States

Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue.

Aug 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cincinnati, United States
$225.0M
raised

CinCor is a clinical-stage biopharmaceutical company that develops treatments for cardiovascular diseases.

Aug 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

$4.0M
raised

Organicell Regenerative Medicine is an exosome therapeutics company with a focus on developing new biologic medicine.

Jul 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 483 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Cambridge, United States
$1.3B
raised

Blueprint Medicines develops precision therapies for genomically defined cancers and rare diseases.

Jun 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ringwood, Australia
$20.9M
raised

Trajan is a biotech company that develops and commercializes technologies that enable analytical systems.

Jun 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Winnipeg, Canada
$1.9M
raised

Delta 9 Cannabis is a company with a large, expanding production facility licensed to produce and sell medical marijuana.

Jun 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Vancouver, Canada
$105.0M
raised

Chinook Therapeutics is a biotechnology company that specializes in the fields of therapeutics and life science.

May 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Macclesfield, United Kingdom
$43.6M
raised

Redx Pharma is a drug discovery and development company.

May 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 483 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Newton, United States
$2.8M
raised

Allena Pharmaceuticals develops and commercializes non-systemic protein therapeutics to treat metabolic and orphan diseases.

May 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Palo Alto, United States
$25.0M
raised

Peak Bio is a biopharmaceutical company that focuses on the drug development to treat Oncology and Inflammatory diseases.

Apr 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

London, United Kingdom
$2.7M
raised

AccuStem Sciences is a life sciences company dedicated to optimizing outcomes for all patients with cancer.

Apr 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Coquitlam, Canada
$3.0M
raised

Entheon is a addiction recovery solution that harnesses and optimizes the therapeutic potential of the DMT molecule.

Apr 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$10.0M
raised

Calithera Biosciences is a pharmaceutical company developing novel small molecule therapeutics for the treatment of cancer.

Mar 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 483 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Kelowna, Canada
$25.8M
raised

The Valens Company is a biotechnology company focused on extraction and the commercialization of cannabinoid-based consumer products.

Mar 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

St Louis, United States
$85.0M
raised

Benson Hill is a provider of crop design platform to develop healthier and more sustainable food and ingredients.

Mar 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Stevenage, United Kingdom
$26.1M
raised

Freeline is a biotechnology company that develops transformative gene therapies for systemic debilitating diseases.

Mar 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Los Angeles, United States
$10.0M
raised

Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer.

Mar 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Minnesota City, United States
$10.9M
raised

Calyxt is an agbiotech company that focuses on developing healthier crops.

Feb 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 483 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
San Francisco, United States
$250.0M
raised

Twist Bioscience is a biotechnology company that offers synthetic DNA solutions, gene synthesis, and variant libraries.

Feb 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Zürich, Switzerland
$5.4M
raised

Xlife Sciences focuses on the performance and growth of life science technologies.

Jan 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Carlsbad, United States
$75.0M
raised

Pardes Biosciences is a biotechnology company that develops and commercializes direct-acting antivirals for the treatment of coronavirus.

Dec 2021
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$1.2B
raised

EQRx is a biotechnology company that focuses on re-engineering the process of drug discovery to make them affordable.

Dec 2021
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$125.0M
raised

Pear Therapeutics is a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals.

Dec 2021
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 451 to 475 of 483 companies

Ready to Connect with Post-IPO Equity Biotechnology Startups?

Get verified founder emails, funding details, and company data for 483 post-ipo equity biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked